Proteomics of hepatocellular carcinoma in chinese patients

OMICS A Journal of Integrative Biology

Volumn 15, Issue 5, 2011, Pages 261-266

  Luk, John M ^a,b   Liu, Angela M ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER DIAGNOSIS; CANCER RELAPSE; CHINESE; DIFFERENTIAL DIAGNOSIS; HUMAN; LIVER CELL CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; HUMANS; LAMIN TYPE B; LIVER NEOPLASMS; PROGNOSIS; PROTEOMICS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79956126873     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0099     Document Type: Review

References (30)

1. Chen, L., Ho, D.W., Lee, N.P., Sun, S., Lam, B., Wong, K.F., et al. (2010). Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker. Ann Surg Oncol 17, 2518-2525.
2. Codarin, E., Renzone, G., Poz, A., Avellini, C., Baccarani, U., Lupo, F., et al. (2009). Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues. J Proteome Res 8, 2273-2284.
3. Feng, J.T., Liu, Y.K., Song, H.Y., Dai, Z., Qin, L.X., Almofti, M.R., et al. (2005). Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5, 4581-4588. (Pubitemid 41739935)
4. Feng, J.T., Shang, S., and Beretta, L. (2006). Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene 25, 3810-3817. (Pubitemid 43980476)
5. Guo, K., Kang, N.X., Li, Y., Sun, L., Gan, L., Cui, F.J., et al. (2009). Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 9, 100.
6. Hao, K., Luk, J.M., Lee, P.Y., Mao, M., Zhang, C., Ferguson, M.D., et al. (2009). Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 9, 389.
7. He QY, Zhu R, Lei T, Ng MY, Luk JM, Sham P, et al. (2008) Toward the proteomic identification of biomarkers for the prediction of HBV-related hepatocellular carcinoma. J Cell Biochem 103, 740-752. (Pubitemid 351240611)
8. Kanmura, S., Uto, H., Kusumoto, K., Ishida, Y., Hasuike, S., Nagata, K., et al. (2007). Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology 45, 948-956. (Pubitemid 46631563)
9. Lee, N.P., Cheung, S.T., Poon, R.T., Fan, S.T., Luk, J.M. (2007). Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma. Biomark Med 1, 273-284.
10. Lee, N.P., Chen, L., Lin, M.C., Tsang, F.H., Yeung, C., Poon, R.T., et al. (2009). Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res 8, 1293-1303.
11. Luk, J.M., Lam, C.T., Siu, A.F., Lam, B.Y., Ng, I.O., Hu, M.Y., et al. (2006). Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6, 1049-1057. (Pubitemid 43260229)
12. Luk, J.M., Lam, B.Y., Lee, N.P., Ho, D.W., Sham, P.C., Chen, L., et al. (2007). Artificial neural networks and decision tree model analysis of liver cancer proteomes. Biochem Biophys Res Commun 361, 68-73. (Pubitemid 47411503)
13. Orimo, T., Ojima, H., Hiraoka, N., Saito, S., Kosuge, T., Kakisaka, T., et al. (2008). Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology 48, 1851-1863.
14. Pang, R.W., Joh, J.W., Johnson, P.J., Monden, M., Pawlik, T.M., Poon, R.T. (2008). Biology of hepatocellular carcinoma. Ann Surg Oncol 15, 962-971.
15. Paradis, V., Degos, F., Dargere, D., Pham, N., Belghiti, J., Degott, C., et al. (2005). Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41, 40-47. (Pubitemid 40066381)
16. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108.
17. Poon, R.T., and Fan, S.T. (2004). Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10, S39-S45. (Pubitemid 38240099)
18. Poon, R.T., Fan, S.T., Lo, C.M., Liu, C.L., and Wong, J. (1999). Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229, 216-222. (Pubitemid 30191795)
19. Santamaria, E., Munoz, J., Fernandez-Irigoyen, J., Prieto, J., Corrales, F.J. (2007). Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics. Liver Int 27, 163-173. (Pubitemid 46680719)
20. Shen, H., Cheng, G., Fan, H., Zhang, J., Zhang, X., Lu, H., et al. (2006). Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential. Proteomics 6, 528-537. (Pubitemid 43208032)
21. Sherman, M. (2001). Alphafetoprotein: an obituary. J Hepatol 34, 603-605. (Pubitemid 32328519)
22. Stefaniuk, P., Cianciara, J., and Wiercinska-Drapalo, A. (2010). Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 16, 418-424.
23. Sun, S., Lee, N.P., Poon, R.T., Fan, S.T., He, Q.Y., Lau, G.K., et al. (2007). Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Liver Int 27, 1021-1038. (Pubitemid 47399436)
24. Sun, S., Poon, R.T., Lee, N.P., Yeung, C., Chan, K.L., Ng, I.O., et al. (2010a). Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors J. Proteome. Res. 9 1923-1930
25. Sun, S., Xu, M.Z., Poon, R.T., Day, P.J., Luk, J.M. (2010b). Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J Proteome Res 9, 70-78.
26. Trevisani, F., D'Intino, P.E., Morselli-Labate, A.M., Mazzella, G., Accogli, E., Caraceni, P., et al. (2001). Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34, 570-575. (Pubitemid 32328514)
27. Yi, X., Luk, J.M., Lee, N.P., Peng, J., Leng, X., Guan, X.Y., et al. (2008). Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 7, 315-325. (Pubitemid 351298446)
28. Yokoo, H., Kondo, T., Okano, T., Nakanishi, K., Sakamoto, M., Kosuge, T., et al. (2007). Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Sci 98, 665-673. (Pubitemid 46563442)
29. Zhang, D., Lim, S.G., and Koay, E.S. (2007). Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int J Oncol 31, 577-584.
30. Zinkin, N.T., Grall, F., Bhaskar, K., Otu, H.H., Spentzos, D., Kalmowitz, B., et al. (2008). Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14, 470-477. (Pubitemid 351226115)